Rigel Pharmaceuticals, Inc. (RIGL)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 10:17AM EDT. Market open.
| Previous Close | 1.0500 |
| Open | 1.0500 |
| Bid | 1.0400 x 200 |
| Ask | 1.0700 x 200 |
| Day's Range | 1.0400 - 1.0900 |
| 52 Week Range | 0.7100 - 1.9600 |
| Volume | |
| Avg. Volume | 1,320,682 |
| Market Cap | 185.052M |
| Beta (5Y Monthly) | 0.98 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?
Silence Therapeutics (SLN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
- GuruFocus.com
Rigel Pharmaceuticals Inc (RIGL) Reports Growth in 2023 Sales, Despite Net Loss for the Year
Key Financial Highlights from Rigel's Earnings Report
- Insider Monkey
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcript
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcript March 5, 2024 Rigel Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to Rigel Pharmaceuticals Financial Conference Call for the Fourth Quarter and Full Year 2023. […]
© 2024 Yahoo. All rights reserved.